Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by juniper88on Oct 25, 2023 8:05pm
110 Views
Post# 35701239

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:National Bank Comments

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:National Bank CommentsI can't see how keeping this board and management can possibly be in the best interest of the shareholders.  When they did the OO they threw then current shareholders under the bus. They now did the same to soleus also. I guess these new investors are a bit smarter in at least getting a seat on the board.


SPCEO1 wrote: I and some friends voted our shares in favor of management and the board last May after speaking to the Chairwoman and making some suggestions about what we wanted to be done. THTX happily took our votes and ignored our suggestions. So, each person can make their own judgment about that.

The we tabled the preferred stock option and basically were ignored. Everyone can make their own judgment about that too, especially given today's announcement.

If this deal fails, clearly change will be in the offing.

If it succeeds, the board will have protected their positions at shareholders expende.

We were looking for just one board seat.We were not looking to make major chamges. We had already decided not to call a special shareholder meeting. And we still have no such plans.

If others want to do do{, you will need 10%of the shares to call one. If one does get called we would vote our shares in the best interests of our shareholders.

The deal needs to fail if anyone wants to call a special meeting as the votes will not be there after the deals closes.
mikeq113 wrote:

One day after Paul emphasized their commitment to shareholder returns...this is pathetic. 


This makes no sense to me but I'm likely out tomorrow morning. Over 300k shares post-split and I'll walk away with a tax loss large enough to last me most of my life. 





<< Previous
Bullboard Posts
Next >>